Voltar
Carta Acesso aberto Revisado por pares
BIBTEX RIS

Malignant hyperthermia and dantrolene sodium

2018; Korean Society of Anesthesiologists; Volume: 72; Issue: 1 Linguagem: Inglês

10.4097/kja.d.18.00139

ISSN

2005-7563

Autores

Ha‐Jung Kim, Won Uk Koh, Jae Moon Choi, Young‐Jin Ro, Hong Seuk Yang,

Tópico(s)

Fuel Cells and Related Materials

Resumo

Recently, there was a case report of malignant hyperthermia in Korea.The patient was treated with conventional methods including dantrolene, but the patient's condition became aggravated, requiring the application of an extracorporeal membrane oxygenator (ECMO) to support cardiopulmonary resuscitation [1].However, if the patient had been treated by prompt administration of dantrolene (i.e., within 20 minutes), we wonder how the patient's clinical course may have progressed.According to the European Malignant Hyperthermia Group guidelines for management of malignant hyperthermia, at least 36 vials of 20 mg dantrolene should be prepared within 10-15 ORCID

Referência(s)